4D Molecular Therapeutics, Inc. (FDMT)
10.07
-0.31
(-2.99%)
USD |
NASDAQ |
Jul 24, 16:00
10.07
0.00 (0.00%)
After-Hours: 20:00
4D Molecular Therapeutics EPS Diluted (Quarterly) : -1.010 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -1.010 |
| December 31, 2025 | 0.3367 |
| September 30, 2025 | -1.013 |
| June 30, 2025 | -0.9773 |
| March 31, 2025 | -0.8606 |
| December 31, 2024 | -1.085 |
| September 30, 2024 | -0.7892 |
| June 30, 2024 | -0.6323 |
| March 31, 2024 | -0.6576 |
| September 30, 2023 | -0.2427 |
| June 30, 2023 | -0.7726 |
| March 31, 2023 | -0.8765 |
| December 31, 2022 | -0.8428 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.7933 |
| June 30, 2022 | -0.8689 |
| March 31, 2022 | -0.8171 |
| December 31, 2021 | -0.8478 |
| September 30, 2021 | -0.823 |
| June 30, 2021 | -0.2838 |
| March 31, 2021 | -0.6147 |
| September 30, 2020 | -0.2936 |
| June 30, 2020 | -0.572 |
| March 31, 2020 | -0.4967 |
| December 31, 2019 | -0.6083 |
| September 30, 2019 | -0.6294 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 3.344 |
| Perspective Therapeutics, Inc. | -0.2528 |
| AnaptysBio, Inc. | -1.843 |
| Precision BioSciences, Inc. | -0.7486 |
| Design Therapeutics, Inc. | -0.2871 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -68.76M |
| Revenue (Quarterly) | 3.047M |
| Total Expenses (Quarterly) | 71.81M |
| Enterprise Value | 156.02M |
| Gross Profit Margin (Quarterly) | 32.56% |
| Profit Margin (Quarterly) | -2.26K% |
| Earnings Yield | -26.46% |
| Normalized Earnings Yield | -26.45 |